Cardiac rehabilitation/exercise in patients with implantable cardioverter defibrillators

• Published in: Journal of the National Medical Association Vol. 88; no. 6; pp. 374 - 378
• Main Authors: FRIEDMAN, A. W, LIPMAN, R. C, SILVER, S. J, MINELLA, R. A, HOOVER, J. L
• Format: Journal Article
• Language: English
• Published: Thorofare, NJ Slack 01.06.1996; National Medical Association
• Subjects: Aged; Arrhythmias, Cardiac - drug therapy; Arrhythmias, Cardiac - rehabilitation; Biological and medical sciences; Defibrillators, Implantable; Diseases of the cardiovascular system; Exercise Test; Exercise Therapy; Humans; Male; Medical sciences; Middle Aged; Postoperative Care; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects); Heart; Physical exercise; Human; Rehabilitation; Implant; Defibrillator
• ISSN: 0027-9684; 1943-4693

There have been no specific exercise or daily activity guidelines determined for patients with automatic implantable cardioverter defibrillators. Two patients, one with a Ventritex Cadence Model V-100 defibrillator and one with a CPI Ventak Model 1550 defibrillator were enrolled in monitored cardiac rehabilitation. One patient had symptoms of syncope and cardiodefibrillation during a vigorous short walk prior to cardiac rehabilitation and became fearful of any activity. Stress testing on this patient was terminated early because his atrial fibrillation rate approached the defibrillization rate. A low dose of beta blockade was added to his regimen. He underwent repeat stress testing and was placed in cardiac rehabilitation. This patient had no further shocks, and it was assumed that his shock was due to high atrial fibrillation rates. The second patient experienced recurrent shocks on amiodarone, propafenone, and mexiletine with presyncope. However, stress testing did not disclose abnormalities. The patient was fearful of any activity and was placed in cardiac rehabilitation. During an average of 26 sessions of cardiac rehabilitation, no symptoms have been noted, and the patients have returned to a more normal lifestyle. Specific exercise and lifestyle criteria should be given to patients with cardioverter defibrillators. Stress testing with monitored exercise can develop such a program. Larger numbers of patients need to be studied.